相关实验视频
Updated: Mar 6, 2026

12:13
Ex Situ Normothermic Machine Perfusion of Donor Livers
Published on: May 26, 2015
12.3K
肝移植中捐赠者和接受者年龄之间的相互作用:对捐赠者和接受者匹配的影响
Charbel Elias1, Jason Mial-Anthony1, Abiha Abdullah1
1Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Transplantation
|March 5, 2026
概括
老年捐赠的肝脏会对年轻的肝脏移植接受者产生负面影响,但老年人不会. 这凸显了需要对年龄有意识的器官分配来改善移植结果的需要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植免疫学 移植免疫学
- 老年医学 老年医学
背景情况:
- 老化的捐赠者和接受者群体需要了解与年龄相关的对肝移植 (LT) 结果的影响.
- 检查捐赠者和接受者年龄的趋势对于优化LT成功至关重要.
- 量化LT年龄差异的影响对于改善患者存活率和移植长寿至关重要.
研究的目的:
- 在肝移植中分析捐赠者和接受者年龄的趋势.
- 评估捐赠者-接受者年龄不匹配对移植后结果的影响.
- 确定影响肝移植成功的年龄门.
主要方法:
- 美国 (2011-2021) 成人和儿科肝移植接受者的分析.
- 评估供体/受体特征,时间趋势和分配模式.
- 多变量考克斯模型用于确定捐赠者年龄对接受者年龄组对生存结果的影响.
主要成果:
- 分析了57,142名LT接受者及其捐赠者的队列,观察到捐赠者和接受者的平均年龄增加 (2011-2021年).
- 增加的供体年龄与患者和移植的5年生存率下降相关,特别是在年轻的接受者 (≤35岁) 中.
- 捐赠者年龄>45岁对年轻的接受者显著增加了死亡率和移植失败风险,而老年接受者 (≥65岁) 的影响最小.
结论:
- 捐赠者年龄不成比例地影响年轻的肝移植接受者.
- 年龄较大的接受者可以容忍较老的捐赠者移植,对生存的影响较小.
- 结果支持年龄意识的器官分配策略,并提供临床决策值.
相关概念视频
Kidney Transplant I: Introduction
606
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
606
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Bone Marrow Sampling and Transplants
2.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.0K
Kidney Transplant II: Surgical Procedure
592
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
592
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
283
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
283
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
306
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
306

